Graham D. Reeve - 07 Nov 2022 Form 4 Insider Report for U S PHYSICAL THERAPY INC /NV (USPH)

Role: COO
Signature: /s/ Graham D Reeve
Issuer symbol: USPH
Transactions as of: 07 Nov 2022
Net transactions value: -$161,864
Form type: 4
Filing time: 08 Nov 2022, 15:47:09 UTC
Previous filing: 10 Aug 2022
Next filing: 23 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	USPH	Common Stock	Sale	$161,864	-1,909	-19%	$84.79	8,083	07 Nov 2022	Reeve Trust	F1
holding	USPH	Common Stock						14,134	07 Nov 2022	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price $84.79 The shares were purchased in multiple transactions at prices ranging from $84.55 to $85.00 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
F2	Includes 14,134 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 2,072 shares on January 1, 2023; 1,412 shares on each of April 1, July 1 and October 1, 2023; 1,418 shares on January 1, 2024; 974 shares on each of April 1, July 1 and October 1, 2024, and on January 1, 2025; 624 shares on each of April 1, July 1 and October 1, 2025; and 640 shares on January 1, 2026, if he is an employee of the Company on those dates.

Content

The price reported is a weighted average price $84.79 The shares were purchased in multiple transactions at prices ranging from $84.55 to $85.00 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

Includes 14,134 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 2,072 shares on January 1, 2023; 1,412 shares on each of April 1, July 1 and October 1, 2023; 1,418 shares on January 1, 2024; 974 shares on each of April 1, July 1 and October 1, 2024, and on January 1, 2025; 624 shares on each of April 1, July 1 and October 1, 2025; and 640 shares on January 1, 2026, if he is an employee of the Company on those dates.